| Neoadjuvant therapy for locally advanced rectal cancer: recent advances and ongoing challenges A Body, H Prenen, M Lam, A Davies, S Tipping-Smith, C Lum, E Liow, ... Clinical colorectal cancer 20 (1), 29-41, 2021 | 28 | 2021 |
| An update on the use of immunotherapy in patients with colorectal cancer M Nguyen, S Tipping Smith, M Lam, E Liow, A Davies, H Prenen, ... Expert review of gastroenterology & hepatology 15 (3), 291-304, 2021 | 23 | 2021 |
| Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: report of a case and review of the literature RS Kotecha, A Buckland, MB Phillips, CH Cole, NG Gottardo Journal of Pediatric Hematology/Oncology 36 (1), 76-80, 2014 | 22 | 2014 |
| Cancer care disparities among Australian and Aotearoa New Zealand indigenous peoples A Davies, J Gurney, G Garvey, A Diaz, E Segelov Current Opinion in Supportive and Palliative Care 15 (3), 162-168, 2021 | 6 | 2021 |
| Anti‐cancer therapy made easier: a 25‐year update A Davies, C Lum, R Raju, E Ansell, K Webber, E Segelov Internal Medicine Journal 51 (4), 473-480, 2021 | 6 | 2021 |
| Comment on: Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic … HG Dholaria, A Davies, RS Kotecha, NG Gottardo, T Walwyn Pediatric Blood & Cancer 65 (8), e27065-e27065, 2018 | 6 | 2018 |
| Stroke in patients with cancer in the era of hyperacute stroke intervention A Davies, L van Leer, J Chan, R Wijayaratna, S Singhal, J Ly, B Clissold, ... Internal Medicine Journal 52 (9), 1513-1518, 2022 | 5 | 2022 |
| Isolated hypogonadotropic hypogonadism secondary to anti-programmed death ligand 1 inhibitor A Davies, N Naderpoor, S Parakh Journal of Thoracic Oncology 14 (7), e147-e148, 2019 | 5 | 2019 |
| 68Ga‐prostate‐specific membrane antigen (PSMA) PET/CT as a clinical decision‐making tool in biochemically recurrent prostate cancer A Davies, M Foo, CL Gan, J Kourambas, N Redgrave, S Donnellan, ... Asia‐Pacific Journal of Clinical Oncology 18 (5), e204-e210, 2022 | 3 | 2022 |
| Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six‐year experience in a large institution S Menon, A Davies, S Frentzas, CA Hawkins, E Segelov, D Day, ... Cancer Reports 5 (2), e1465, 2022 | 3 | 2022 |
| Exploration of the use and impact of patient-reported experience measures (PREMs) in oncology settings: A systematic review. O Cook, Y Daiyan, L Yeganeh, AG Davies, A Kwok, K Webber, E Segelov Journal of Clinical Oncology 38 (29_suppl), 166-166, 2020 | 3 | 2020 |
| Genomic alterations to guide treatment selection in metastatic prostate cancer A Davies, AA Azad, EM Kwan Critical Reviews™ in Oncogenesis 27 (1), 2022 | 2 | 2022 |
| PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer T Scheinberg, HM Lin, M Fitzpatrick, AA Azad, P Bonnitcha, A Davies, ... Prostate Cancer and Prostatic Diseases 27 (1), 136-143, 2024 | 1 | 2024 |
| 432P Representation of countries and gender in abstracts at the 2022 American Society of Clinical Oncology Annual Scientific Meeting (ASCO ASM) LA Teuwen, J Young, A Davies, J Hudson, MTB de los Rios, H Prenen, ... Annals of Oncology 33, S1609, 2022 | 1 | 2022 |
| Adult medulloblastoma in an Australian population S Parakh, A Davies, K Westcott, D Roos, A Abou-Hamden, E Ahern, ... Journal of Clinical Neuroscience 102, 65-70, 2022 | 1 | 2022 |
| P01. 22 outcomes in NSCLC patients with early termination of immune checkpoint inhibitors due to toxicities A Davies, S Menon, M Alamgeer Journal of Thoracic Oncology 16 (3), S245, 2021 | 1 | 2021 |
| Interim position emission tomography-computed tomography during multimodality treatment of locally advanced esophageal cancer: a scoping review H Zhu, S Hao, I Tseng, J Shen, ER Del Campo, A Davies, E Segelov, ... Quantitative imaging in medicine and surgery 13 (9), 6280, 2023 | | 2023 |
| 278MO Adherence optimisation, benefits, and limitations of oral anti-cancer therapy: A systematic review of patient preferences AG Davies, D Buckley, A Raghunath, K Martin, H Prenen, O Cook, ... Annals of Oncology 33, S1541-S1542, 2022 | | 2022 |
| Incidence and management of severe immune-related adverse events in a regional Australian setting A Davies, D Roscoe, T Wright, M Iddawela ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 18, 170-170, 2022 | | 2022 |
| 1409P Development of a clinically accessible, circulating prognostic lipid biomarker panel in men with mCRPC to guide potential metabolic intervention T Scheinberg, M Fitzpatrick, HM Lin, AA Azad, P Bonnitcha, AG Davies, ... Annals of Oncology 33, S1189, 2022 | | 2022 |
